MapLight Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MPLT and other ETFs, options, and stocks.About MPLT
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP.
MPLT Key Statistics
Stock Snapshot
With a market cap of 1.21B, MapLight Therapeutics(MPLT) trades at $28.61. The stock has a price-to-earnings ratio of -7.70.
On 2026-05-05, MapLight Therapeutics(MPLT) shares started trading at $30.55, with intraday highs of — and lows of —.
Trading volume for MapLight Therapeutics(MPLT) stock has reached 0, versus its average volume of 387.91K.
The stock's 52-week range extends from a low of $12.24 to a high of $33.28.
The stock's 52-week range extends from a low of $12.24 to a high of $33.28.
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.